| Title : UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy? - Schulz_2009_Anticancer.Drugs_20_867 |
| Author(s) : Schulz C , Boeck S , Heinemann V , Stemmler HJ |
| Ref : Anticancer Drugs , 20 :867 , 2009 |
| Abstract : |
| PubMedSearch : Schulz_2009_Anticancer.Drugs_20_867 |
| PubMedID: 19770637 |
| Title : UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy? - Schulz_2009_Anticancer.Drugs_20_867 |
| Author(s) : Schulz C , Boeck S , Heinemann V , Stemmler HJ |
| Ref : Anticancer Drugs , 20 :867 , 2009 |
| Abstract : |
| PubMedSearch : Schulz_2009_Anticancer.Drugs_20_867 |
| PubMedID: 19770637 |
| Title : UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy? - Schulz_2009_Anticancer.Drugs_20_867 |
| Author(s) : Schulz C , Boeck S , Heinemann V , Stemmler HJ |
| Ref : Anticancer Drugs , 20 :867 , 2009 |
| Abstract : |
| PubMedSearch : Schulz_2009_Anticancer.Drugs_20_867 |
| PubMedID: 19770637 |